GlucoMe, a comprehensive, digital diabetes care platform that intends to streamlines the disease management process for patients, medical teams and healthcare providers, announced yesterday that it has collaborated with Switzerland-based Roche as a new partner due to its involvement in the current Startup Creasphere Batch 2 Program.
Set-up by Roche and Plug and Play to accelerate digital healthcare Startup Creasphere is the first digital health innovation hub in Europe. GlucoMe was chosen to collaborate with Roche from one of 11 companies that are participating in the global initiative, following a screening process of more than 200 health-focused start-up companies.
GlucoMe's CEO, Yiftah Ben-Aharon, said, 'We are excited to partner with Roche and Plug & Play. From some very tough competition involving world-class promising digital health start-ups, the new Roche partnership will help GlucoMe rapidly advance our digital diabetes platform to set a new standard in diabetes care delivery.'
Innovent reports first participant dosed in new Phase 3 trial of mazdutide in China
Vivoryon Therapeutics presents positive meta-analysis data for varoglutamstat
Camurus and Lilly agree licensing deal for FluidCrystal incretins
Genprex signs new research agreement with University of Pittsburgh to advance diabetes gene therapy